Valion Bio Inc (VBIO) Stock Price, Quote & News

Company Profile

Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications, such as immunosenescence. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, In...

Industry: Biotechnology

Sector: Healthcare

Phone: 888 276 6888

Website: tivichealth.com

Address:

1305 E. Houston Street, Suite 311, Building 1, San Antonio, United States

urgetosurge May. 13 at 11:59 AM

$VBIO shares to borrow at Schwab went from 33k to 57k overnight.

0 · Reply

YoloAlfred May. 13 at 11:28 AM

$NXTS $VBIO look at its news feed

0 · Reply

YoloAlfred May. 13 at 9:26 AM

$VBIO Im talking stock price

0 · Reply

YoloAlfred May. 13 at 9:25 AM

$VBIO add at least 1,000 shares. Max pain .50 cents max gain $50

0 · Reply

Eugen337 May. 13 at 6:10 AM

$VBIO May 14th financial countdown? Do you think this could leap towards the moon? Should I buy it today? It's a very dark horse. My mind says don't bother and pass it by. My subconscious says give it a try; it's a rocket ship. What are your thoughts?

0 · Reply

urgetosurge May. 12 at 11:52 PM

$VBIO this stock reminds me of many others in the bitcoin and quantum stocks that sat at these sub values levels only to explode when the sector was thoroughly rung out of shareholders. Look at all these shite china stocks, with share selling programs as their only product. This stock could waffle dormant... until it's time to rock. Book it.

0 · Reply

urgetosurge May. 12 at 7:36 PM

$VBIO mms losing inventory.

0 · Reply

YoloAlfred May. 12 at 7:15 PM

$VBIO .....

1 · Reply

urgetosurge May. 12 at 7:13 PM

$VBIO mms algos working hard here. Something up..

0 · Reply

urgetosurge May. 12 at 7:04 PM

$VBIO shuffle shuffle, ah event??

0 · Reply

Valion Bio to Report First Quarter 2026 Financial Results on May 14, 2026

May 6, 2026, 8:08 AM EDT - 7 days ago

Valion Bio Celebrates Grand Opening of Velocity Bioworks Biomanufacturing Facility in San Antonio, Anchoring Domestic Production of Entolimod™

2026-05-05T12:15:18.000Z - 8 days ago

Valion Bio receives first study protocol under agreement with NIAID

May 5, 2026, 8:00 AM EDT - 8 days ago

VALION BIO RECEIVES FIRST FDA-PRECEDENT STUDY PROTOCOL FROM NIAID FOR ENTOLIMOD™; FEDERAL AGENCY TO FULLY FUND BLA-ENABLING IN VIVO PROGRAM AND CO-NAVIGATE FDA SUBMISSION

2026-05-04T20:42:49.000Z - 8 days ago

Valion Bio names Melinda Lackey as General Counsel

TCRT

May 4, 2026, 4:05 PM EDT - 8 days ago

Valion Bio Appoints Melinda Lackey as General Counsel

TCRT

Apr 28, 2026, 8:01 AM EDT - 15 days ago

VALION BIO BRIEFS PENTAGON LEADERSHIP ON ENTOLIMOD™ FOR ACUTE RADIATION SYNDROME

Apr 23, 2026, 4:05 PM EDT - 19 days ago

Tivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple Revenue Stream Model

Apr 15, 2026, 8:00 AM EDT - 4 weeks ago

Tivic Health Selected to Present Entolimod™ as a Radiation Countermeasure and its Plans for an Oral Transmucosal Program to the Department of War Tech Watch Program on May 7th

Apr 1, 2026, 2:55 PM EDT - 5 weeks ago

Valion Bio Transcript: Emerging Growth Conference 91

Mar 31, 2026, 8:30 AM EDT - 6 weeks ago

Tivic Receives Formal Request for Information from Ukrainian Ministry of Health Regarding Strategic Stockpiling of Entolimod

Mar 27, 2026, 11:30 AM EDT - 6 weeks ago

Tivic CEO To Present at the Upcoming Emerging Growth's April 2026 Virtual Conference

Mar 26, 2026, 8:30 AM EDT - 6 weeks ago

Tivic Secures NIAID Non-Clinical Evaluation Agreement for Entolimod, Targeting Gastrointestinal Acute Radiation Syndrome

Mar 25, 2026, 4:30 PM EDT - 6 weeks ago

Valion Bio Earnings Call Transcript: Q4 2025

Mar 25, 2026, 4:05 PM EDT - 6 weeks ago

Tivic Reports Full Year 2025 Results

Mar 24, 2026, 9:30 AM EDT - 7 weeks ago

Tivic Health CEO Letter to Shareholders

Mar 20, 2026, 3:35 PM EDT - 7 weeks ago

Tivic To Report 2025 Year-End Financial Results Via Conference Call and Webcast on March 25th at 1:30pm PT / 4:30pm ET

Mar 12, 2026, 4:00 PM EDT - 2 months ago

Valion Bio Transcript: EGM 2026

Mar 4, 2026, 8:30 AM EST - 2 months ago

Biotech Veteran Michael K. Handley Named CEO of Tivic Health Systems to Spearhead Strategic Expansion in Biopharma

Feb 18, 2026, 9:15 AM EST - 2 months ago

Tivic and BARDA Continue Discussions of Entolimod for Acute Radiation Syndrome on March 10

Jan 28, 2026, 8:30 AM EST - 3 months ago

Tivic, BARDA Discuss Entolimod(TM) for Acute Radiation Syndrome at TechWatch Meeting

Jan 26, 2026, 10:10 AM EST - 3 months ago

Tivic to Showcase Strategic Pivot and Forward Outlook on Advancing Entolimod(TM) to Commercialization at DealFlow Discovery Conference

Jan 22, 2026, 4:10 PM EST - 3 months ago

Valion Bio Transcript: Emerging Growth Conference 89

Jan 20, 2026, 5:50 PM EST - 4 months ago

Tivic CEO To Present at the Upcoming Emerging Growth's January 2026 Virtual Conference

Jan 12, 2026, 4:30 PM EST - 4 months ago

Valion Bio Transcript: Investor Update

Jan 12, 2026, 9:00 AM EST - 4 months ago

Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug Candidate Entolimod(TM) And Achieves Reproducible Yields, Potency and Purity

Jan 8, 2026, 8:30 AM EST - 4 months ago

Tivic Announces Special Webcast To Discuss Its Recent Acquisition of CDMO Assets - Highlighting Near-Term Strategic Potential and Immediate Contributions to Accelerated Drug Development Timelines

Dec 11, 2025, 9:45 AM EST - 5 months ago

Tivic Acquires Ready-to-Scale cGMP Manufacturing and Development Assets to Accelerate Commercialization of Entolimod; Tivic Growth Backed By $90M+ Financing Package

Nov 18, 2025, 8:30 AM EST - 6 months ago

Tivic Secures Barda Meeting for Entolimod(TM) for Acute Radiation Syndrome

Nov 14, 2025, 4:30 PM EST - 6 months ago

Tivic Reports Third Quarter 2025 Financial Results

Nov 14, 2025, 4:30 PM EST - 6 months ago

Valion Bio Earnings Call Transcript: Q3 2025

Nov 13, 2025, 8:30 AM EST - 6 months ago

Tivic Health Reports Findings of Clinical Optimization Trial of Non-Invasive Cervical Vagus Nerve Stimulation (ncVNS)

Nov 10, 2025, 9:00 AM EST - 6 months ago

Tivic Expands Intellectual Property Portfolio

Nov 6, 2025, 9:30 AM EST - 6 months ago

Tivic Health to Report Third Quarter 2025 Financial Results on November 14th Via Conference Call and Webcast

Oct 22, 2025, 2:00 PM EDT - 7 months ago

Tivic CEO, Jennifer Ernst, to Join Panel at 8th Annual Northwell Health Innovation Constellation Forum on Thursday, Oct. 23

Sep 25, 2025, 11:25 AM EDT - 8 months ago

Valion Bio Transcript: Emerging Growth Conference 2025

Sep 22, 2025, 8:30 AM EDT - 8 months ago

Tivic Health CEO Jennifer Ernst to Present at Emerging Growth's September Virtual Conference

Sep 10, 2025, 8:30 AM EDT - 8 months ago

Tivic Completes Verification of Entolimod™ Cell Line: First Step in Establishing CGMP Manufacturing for BLA Filing

Aug 20, 2025, 8:30 AM EDT - 9 months ago

Tivic Receives Two Investigational New Drug Applications for Entolimod™ for the Treatment of Acute Radiation Syndrome (ARS) and Advanced Cancers

Aug 15, 2025, 8:30 AM EDT - 9 months ago

Tivic Health Advances Discussions on Use of Entolimod as a Radiation Countermeasure at Military Health System Research Symposium 2025

Aug 14, 2025, 4:30 PM EDT - 9 months ago

Valion Bio Earnings Call Transcript: Q2 2025

Aug 14, 2025, 4:00 PM EDT - 9 months ago

Tivic Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 8:30 AM EDT - 9 months ago

Tivic Health to Report Second Quarter 2025 Financial Results on August 14th Via Conference Call and Webcast

Jul 8, 2025, 8:30 AM EDT - 11 months ago

Tivic Shareholders Approve Key Proposals in Support of Strategic Transformation; Lisa Wolf Appointed Permanent CFO

Jun 25, 2025, 8:30 AM EDT - 11 months ago

Tivic Health Completes Optimization Study for Its Non-Invasive Vagus Nerve Stimulation Device

Jun 24, 2025, 8:30 AM EDT - 11 months ago

Tivic Health Announces 2025 Annual Meeting of Stockholders

Jun 11, 2025, 1:30 PM EDT - 11 months ago

Valion Bio Transcript: Life Sciences Virtual Investor Forum

May 22, 2025, 1:00 PM EDT - 1 year ago

Valion Bio Transcript: Sidoti May Micro-Cap Virtual Conference

May 15, 2025, 4:30 PM EDT - 1 year ago

Valion Bio Earnings Call Transcript: Q1 2025

May 15, 2025, 4:05 PM EDT - 1 year ago

Tivic Reports First Quarter 2025 Financial Results and Provides Updates on Business Transformation

May 14, 2025, 8:30 AM EDT - 1 year ago

Tivic Health Enters GMP Manufacturing Validation Agreement with Scorpius BioManufacturing in Preparation for FDA Submission

May 13, 2025, 8:30 AM EDT - 1 year ago

Tivic Expands VNS Intellectual Property Portfolio

May 9, 2025, 8:30 AM EDT - 1 year ago

Tivic Health to Report First Quarter 2025 Financial Results on May 15th Via Conference Call and Webcast

Apr 22, 2025, 8:30 AM EDT - 1 year ago

Tivic Health Reports White House Briefing and FDA Meetings Secured Positive Interest in Potential Military and Defense Applications of Its Product Candidates

Apr 15, 2025, 8:30 AM EDT - 1 year ago

Tivic Health Extends its Worldwide License of TLR5 Agonist Entolimod to Include the Treatment of Neutropenia

Apr 10, 2025, 8:30 AM EDT - 1 year ago

Tivic Health Systems, Inc. Regains Compliance with NASDAQ Minimum Bid Price Listing Rule

Mar 21, 2025, 4:30 PM EDT - 1 year ago

Valion Bio Earnings Call Transcript: Q4 2024

Mar 21, 2025, 4:00 PM EDT - 1 year ago

Tivic Reports Year End 2024 Financial Results and Provides Overview of Strategy for Transformation and Growth

Mar 13, 2025, 4:59 PM EDT - 1 year ago

Tivic Health to Report 2024 Year-End Financial Results on March 21st Via Conference Call and Webcast

Mar 6, 2025, 8:15 AM EST - 1 year ago

Tivic Health and Feinstein Institute Present New Data Showing Personalized Vagus Nerve Stimulation Method Optimizes Impact on Autonomic Nervous System

Mar 5, 2025, 8:15 AM EST - 1 year ago

Tivic Health Systems, Inc. Announces Reverse Stock Split

Mar 3, 2025, 8:15 AM EST - 1 year ago

Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve

Feb 24, 2025, 8:15 AM EST - 1 year ago

Tivic Health Names Biotech Industry Veteran Michael K. Handley to Executive Leadership Team

Feb 12, 2025, 8:30 AM EST - 1 year ago

Tivic Health Acquires Exclusive Worldwide Rights to Phase III TLR5 Agonist from Statera Biopharma

urgetosurge May. 13 at 11:59 AM

$VBIO shares to borrow at Schwab went from 33k to 57k overnight.

0 · Reply

YoloAlfred May. 13 at 11:28 AM

$NXTS $VBIO look at its news feed

0 · Reply

YoloAlfred May. 13 at 9:26 AM

$VBIO Im talking stock price

0 · Reply

YoloAlfred May. 13 at 9:25 AM

$VBIO add at least 1,000 shares. Max pain .50 cents max gain $50

0 · Reply

Eugen337 May. 13 at 6:10 AM

0 · Reply

urgetosurge May. 12 at 11:52 PM

0 · Reply

urgetosurge May. 12 at 7:36 PM

$VBIO mms losing inventory.

0 · Reply

YoloAlfred May. 12 at 7:15 PM

$VBIO .....

1 · Reply

urgetosurge May. 12 at 7:13 PM

$VBIO mms algos working hard here. Something up..

0 · Reply

urgetosurge May. 12 at 7:04 PM

$VBIO shuffle shuffle, ah event??

0 · Reply

YoloAlfred May. 12 at 7:02 PM

$VBIO Nasty market day.....it is kinda needed

0 · Reply

urgetosurge May. 12 at 6:56 PM

$VBIO mms printing the buys as sells, painting the tape but the accumulation index doesn't lie. Shake shake shake..

0 · Reply

urgetosurge May. 12 at 6:43 PM

$VBIO added and orders in below. Shorts playing with fire here. Nominal borrowed shares and yet still allowing the dips. Obviously by permission. Mms must have buy orders to fill.

0 · Reply

urgetosurge May. 12 at 5:56 PM

$VBIO the reality of the times we are living in. Non competitive proprietary necessity. Surreal, but the unfortunate side of humanity.

0 · Reply

OldManLogan May. 12 at 5:49 PM

$VBIO It's actually been fun watching the watchers list grow, lol... I think it was 42 when I first looked at the board not that long ago! Suspect it jumps up violently once they put out a PR with some meat on the bones.

0 · Reply

urgetosurge May. 12 at 5:42 PM

$VBIO 6 bones just for asset purchases, not including the real asset values at 80 million of purchasing pieces. Factor in pipe financing of 50 million, boom..

0 · Reply

Team_Zissou May. 12 at 5:29 PM

$VBIO 56 watchers when I posted this 16 hours ago, 73 now - up 30%! Still incredibly under the radar, need to keep getting 30% more watchers several days in a row here

0 · Reply

urgetosurge May. 12 at 5:04 PM

$VBIO average daily volume is trending up now at 300k

0 · Reply

urgetosurge May. 12 at 5:01 PM

$VBIO schwab had 3.1 million shares outstanding.

0 · Reply

urgetosurge May. 12 at 4:12 PM

$VBIO algos another term for market manipulation criminal racketeering. That's what passes for free market economics. Sanctioned by the biggest racketeering agency, the federal government. The very ones that'll bust out the wallets to save their asses... what a oxymoron..

0 · Reply

urgetosurge May. 12 at 4:05 PM

$VBIO share borrowed to return should pop this by eod..

0 · Reply

urgetosurge May. 12 at 3:57 PM

$VBIO beautiful set up for next leg. https://stockcharts.com/sc3/ui/?s=VBIO

0 · Reply

Market Cap	19.97M
Revenue (ttm)	0.00
Net Income (ttm)	-880,000.00
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	73,300
Avg Vol	309,014
Day's Range	N/A - N/A
Shares Out	51.20M
Stochastic %K	19%
Beta	4.09
Analysts	Strong Buy
Price Target	$3.50